Lactoferrin and Aging: Geroscience Mechanisms and Longevity Potential
Expert Summary
The connection between lactoferrin and aging biology is grounded in iron homeostasis. As organisms age, iron regulation deteriorates: ferritin rises, transferrin saturation increases, and free labile iron accumulates in tissues — driving Fenton chemistry, mitochondrial damage, and activation of cellular senescence pathways. Lactoferrin, which declines with age, is one of the body's primary iron-sequestration mechanisms. Restoring lactoferrin bioavailability is a geroscience-aligned strategy for managing age-associated iron dysregulation.
Key Facts
- Lactoferrin declines with age: Secretory lactoferrin levels in mucosal tissues, saliva, and breast secretions decline with advancing age. This reduction coincides with increased susceptibility to infection, gut permeability, and systemic inflammation in older adults.
- Iron dysregulation as an aging driver: Tissue iron accumulation accelerates with age. Labile iron catalyzes hydroxyl radical formation via Fenton chemistry — damaging DNA, lipids, mitochondria, and activating NF-κB inflammatory signaling. The senescence secretome (SASP) is iron-dependent; excess iron amplifies SASP and promotes paracrine senescence in neighboring cells.
- Lactoferrin and senolytic context: While not classified as a senolytic (it does not selectively eliminate senescent cells), lactoferrin may reduce SASP intensity by limiting iron availability for inflammatory signaling. This positions it as a senomorphic (senescence-modifying) agent in geroscience terminology.
- Mitochondrial iron and aging: Mitochondria accumulate excess iron with age, impairing electron transport chain function and increasing mitochondrial ROS. Lactoferrin's systemic iron chelation reduces the iron available for mitochondrial accumulation, potentially slowing mitochondrial dysfunction.
- Animal lifespan data: Lactoferrin supplementation has extended median lifespan in Caenorhabditis elegans models by up to 23% in some studies. Mechanisms appear to involve reduction in oxidative stress and iron-mediated toxicity. Mouse studies show reduced oxidative damage markers with chronic lactoferrin supplementation.
- Clinical aging markers: Older adults supplementing lactoferrin show reductions in IL-6 and TNF-alpha, two cytokines associated with inflammaging — the chronic low-grade inflammation characteristic of aging.
Recommended Products
Frequently Asked Questions
Should older adults take more lactoferrin than younger adults?
Given that circulating lactoferrin declines with age, older adults may benefit from the higher end of the standard dosing range (300-600 mg/day) compared to younger adults using lactoferrin for immune support (200-300 mg/day). No age-specific dose guidelines exist yet from clinical research.
Scientific References
- Lönnerdal B. Nutritional and physiologic significance of human milk proteins. American Journal of Clinical Nutrition. 2003. PMID: 12540398
- Kruzel ML et al. Lactoferrin in health and disease: state of the art. International Journal of Molecular Sciences. 2021